Skip Navigation
Skip to contents

Epidemiol Health : Epidemiology and Health

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse articles > Author index
Search
Jade Khalife 1 Article
COVID-19 herd immunity in the absence of a vaccine: an irresponsible approach
Jade Khalife, Derrick VanGennep
Epidemiol Health. 2021;43:e2021012.   Published online February 3, 2021
DOI: https://doi.org/10.4178/epih.e2021012
  • 13,865 View
  • 377 Download
  • 11 Web of Science
  • 11 Crossref
AbstractAbstract AbstractSummary PDF
Abstract
As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread rapidly throughout the human population, the concept of “herd immunity” has attracted the attention of both decision-makers and the general public. In the absence of a vaccine, this entails that a large proportion of the population will be infected to develop immunity that would limit the severity and/or extent of subsequent outbreaks. We argue that adopting such an approach should be avoided for several reasons. There are significant uncertainties about whether achieving herd immunity is possible. If possible, achieving herd immunity would impose a large burden on society. There are gaps in protection, making it difficult to shield the vulnerable. It would defeat the purpose of avoiding harm caused by the virus. Lastly, dozens of countries are showing that containment is possible.
Summary
Key Message
Pursuing herd immunity without a vaccine involves numerous uncertainties, is costly in terms of lives and disease, is ineffective, and - being unethical and uncompassionate - is not compatible with human dignity and development.

Citations

Citations to this article as recorded by  
  • Mathematical assessment of the roles of age heterogeneity and vaccination on the dynamics and control of SARS-CoV-2
    Binod Pant, Abba B. Gumel
    Infectious Disease Modelling.2024; 9(3): 828.     CrossRef
  • Assessing the Impact of Risk Factors on Vaccination Uptake Policy Decisions Using a Bayesian Network (BN) Approach
    Hafiz Waqar Abbas, Zaman Sajid, Uyen Dao
    Systems.2024; 12(5): 167.     CrossRef
  • COVID-19, Herd Immunity and Vaccine
    Sim Sai Tin, Viroj Wiwanitkit
    International Journal of Preventive Medicine.2023;[Epub]     CrossRef
  • Analyzing natural herd immunity media discourse in the United Kingdom and the United States
    Marco Zenone, Jeremy Snyder, Alessandro Marcon, Timothy Caulfield, Veena Sriram
    PLOS Global Public Health.2022; 2(1): e0000078.     CrossRef
  • Evaluation of science advice during the COVID-19 pandemic in Sweden
    Nele Brusselaers, David Steadson, Kelly Bjorklund, Sofia Breland, Jens Stilhoff Sörensen, Andrew Ewing, Sigurd Bergmann, Gunnar Steineck
    Humanities and Social Sciences Communications.2022;[Epub]     CrossRef
  • Is COVID-19 Herd Immunity Influenced by Population Densities of Cities?
    Yuval Arbel, Yifat Arbel, Amichai Kerner, Miryam Kerner
    Sustainability.2022; 14(16): 10286.     CrossRef
  • Effective strategies against COVID-19 and the importance of infection sequelae
    Jade Khalife
    Global Health Research and Policy.2022;[Epub]     CrossRef
  • Psychological aspects of COVID-19 vaccine in Indian population. Are we still hesitant?
    Raza Shaheed, Sourya Acharya, Samarth Shukla, Monika Kesarwani, Neema Acharya
    Journal of Family Medicine and Primary Care.2022; 11(8): 4280.     CrossRef
  • Herd immunity: challenges and the way forward in Korea
    Jiyoung Oh, Sohyun Kim, Boyeong Ryu, Minjoung Shin, Bryan Inho Kim
    Epidemiology and Health.2021; 43: e2021054.     CrossRef
  • COVID-19 vaccine uptake and vaccine hesitancy in Indian patients with cancer
    Vanita Noronha, George Abraham, Suresh Kumar Bondili, Annu Rajpurohit, Rakesh P. Menon, Shreya Gattani, Mehak Trikha, Rajanigandha Tudu, Kishore Kumar Kota, Ajay Kumar Singh, Prahalad Elamarthi, Goutam Santosh Panda, Rahul Kumar Rai, Madala Ravi Krishna,
    Cancer Research, Statistics, and Treatment.2021; 4(2): 211.     CrossRef
  • COVID-19 vaccine hesitancy in India
    Mihir Tusharbhai Dani, Arjun Gurmeet Singh, Pankaj Chaturvedi
    Cancer Research, Statistics, and Treatment.2021; 4(3): 437.     CrossRef

Epidemiol Health : Epidemiology and Health
TOP